These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31332492)

  • 1. Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.
    Abdel-Rahman O
    World J Surg; 2019 Nov; 43(11):2927-2933. PubMed ID: 31332492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of current versus former smoking status on the outcomes of non-metastatic non-small cell lung cancer treated with upfront surgery; findings from the National Lung Screening Trial.
    Abdel-Rahman O
    Expert Rev Respir Med; 2019 Jun; 13(6):585-591. PubMed ID: 31055993
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study.
    Sun Z; Sui X; Yang F; Wang J
    Lung Cancer; 2019 Mar; 129():98-106. PubMed ID: 30545693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
    Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
    Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
    Balekian AA; Wisnivesky JP; Gould MK
    Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Bugge AS; Lund MB; Valberg M; Brustugun OT; Solberg S; Kongerud J
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):221-227. PubMed ID: 28950311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer.
    Taniguchi Y; Fukumoto K; Matsui H; Saito T; Murakawa T
    Gen Thorac Cardiovasc Surg; 2019 Jul; 67(7):615-623. PubMed ID: 30659509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
    Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
    Park SJ; Lee CS; Chung SS
    Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
    Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
    Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.